FREE Account Opening + No Clearing Fees
Loading...

Gland Pharma IPO vs Mazagon Dock IPO

Comparision between Gland Pharma IPO and Mazagon Dock IPO.

IPO Details

Gland Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mazagon Dock IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Gland Pharma IPO is up to ₹6,479.55 Cr whereas the issue size of the Mazagon Dock IPO is up to ₹443.69 Cr. The final issue price of Gland Pharma IPO is ₹1,500.00 per share and of Mazagon Dock IPO is ₹145.00 per share.

  Gland Pharma IPO Mazagon Dock IPO
Face Value ₹1 per share ₹10 per share
Issue Price (Lower) ₹1,490.00 per share ₹135.00 per share
Issue Price (Upper) ₹1,500.00 per share ₹145.00 per share
Issue Price (Final) ₹1,500.00 per share ₹145.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 10 shares 103 shares
Fresh Issue Size 83,33,333 shares
Fresh Issue Size (Amount) up to ₹1,250.00 Cr
OFS Issue Size 3,48,63,635 shares 3,05,99,017 shares
OFS Issue Size (Amount) up to ₹5,229.55 Cr up to ₹443.69 Cr
Issue Size Total 4,31,96,968 shares 3,05,99,017 shares
Issue Size Total (Amount) up to ₹6,479.55 Cr up to ₹443.69 Cr

IPO Timetable

Gland Pharma IPO opens on Nov 09, 2020, while Mazagon Dock IPO opens on Sep 29, 2020. The closing date of Gland Pharma IPO and Mazagon Dock IPO is Nov 11, 2020, and Oct 01, 2020, respectively.

  Gland Pharma IPO Mazagon Dock IPO
Anchor Bid Date
Issue Open Nov 09, 2020 Sep 29, 2020
Issue Close Nov 11, 2020 Oct 01, 2020
Basis Of Allotment (Tentative) Nov 17, 2020 Oct 07, 2020
Initiation of Refunds (Tentative) Nov 18, 2020 Oct 08, 2020
Credit of Share (Tentative) Nov 19, 2020 Oct 09, 2020
Listing date (Tentative) Nov 20, 2020 Oct 12, 2020
Anchor Lockin End date 1 Dec 17, 2020 Nov 06, 2020
Anchor Lockin End date 2 Feb 15, 2021 Jan 05, 2021

Financials

Gland Pharma IPO P/E ratio is , as compared to Mazagon Dock IPO P/E ratio of .

  Gland Pharma IPO Mazagon Dock IPO
Financial
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
30-June-20 31-Mar-20 31-Mar-19 31-Mar-18
Total Assets 46,912.65 40,860.39 35,235.49 29,294.68
Total Revenue 9,162.89 27,724.08 21,297.67 16,716.82
Profit After Tax 3,135.90 7,728.58 4,518.56 3,210.51
Summary of financial Information (Restated Consolidated)
Particulars For the year/period ended (Rs in million)
31-Mar-20 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 209,660.28 208,479.34 193,703.72 193,911.65
Total Revenue 55,353.07 52,046.74 50,276.29 42,748.63
Profit After Tax 4,770.59 5,324.74 4,961.73 5,982.58
Promoter Shareholding (Pre-Issue) 74% 100%
Promoter Shareholding (Post-Issue) 58% 85%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Gland Pharma IPO retail investors (RII) are offered 1,51,18,939 shares while in Mazagon Dock IPO retail investors are offered 1,51,18,939 shares. Qualified institutional buyers (QIB) are offered 86,39,394 shares in Gland Pharma IPO and 1,51,26,750 shares in Mazagon Dock IPO.

  Gland Pharma IPO Mazagon Dock IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 86,39,394 shares 1,51,26,750 shares
NII 64,79,546 shares 45,38,025 shares
RII 1,51,18,939 shares 1,05,88,725 shares
Employee 0 shares 3,45,517 shares
Others
Total 3,02,37,879 shares 3,05,99,017 shares

Bids Received (Subscription)

Gland Pharma IPO subscribed 2.06x in total, whereas Mazagon Dock IPO subscribed 157.41x.

  Gland Pharma IPO Mazagon Dock IPO
QIB (times) 6.40x 89.71x
NII (times) 0.51x 678.88x
Big NII (times)
Small NII (times)
RII (times) 0.24x 35.63x
Employee (times) 3.88x
Other (times)
Total (times) 2.06x 157.41x

Comments

Add a public comment...